Education
About Us
Working with TipRanks
Follow Us
AbbVie (ABBV)
NYSE:ABBV
Emraclidine
Healthy Volunteer
Phase I
Recruiting
A Study to Assess the Adverse Events and How Oral Emraclidine Moves Through the Body of Healthy Elderly Adult Participants
Oct 17, 2025
―
Abbv-1354
Healthy Volunteer
Phase I
Recruiting
A Study to Assess the Mass Balance of Oral ABBV-1354 in Healthy Adult Male Participants
Oct 17, 2025
―
Elapr002f Injectable Gel, Saline Control
Acne Scars
Phase III
Not Yet Recruiting
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
Oct 02, 2025
―
Telisotuzumab Adizutecan
Solid Tumors Harboring Met Amplification
Phase II
Not Yet Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
Sep 22, 2025
―
Juvéderm Volux Xc, Juvéderm Voluma Xc, Juvéderm Volbella Xc, Juvéderm Vollure Xc, Skinvive By Juvéderm, Juvéderm Ultra Xc, Juvéderm Ultra Plus Xc
Mid Face Volume Deficit
Phase IV
Recruiting
A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial Appearance
Sep 16, 2025
―
Telisotuzumab Adizutecan, Standard of Care
Non-small Cell Lung Cancer
Phase II/III
Not Yet Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Aug 28, 2025
Carboplatin, Etoposide, Atezolizumab, Lurbinectedin, Abbv-706
Small Cell Lung Cancer
Phase II/III
Not Yet Recruiting
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
Aug 28, 2025
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does AbbVie (ABBV) have in its pipeline
ABBV is currently developing the following drugs: Emraclidine, Abbv-1354, Elapr002f Injectable Gel, Saline Control. These drug candidates are in various stages of clinical development as the company works toward FDA approval.